Dow Jones

44,424.25

-0.32%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Inter-amer 30 (BC43)

Inter-amer 30

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:BC43

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
13/11/2002	14:09	UK Regulatory	Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly Senior Vice President, General Counsel	LSE:BC43	Inter-amer 30
09/11/2002	09:30	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
08/11/2002	12:30	UK Regulatory	Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities and Deliver Superior Earnings Growth Over the Lon	LSE:BC43	Inter-amer 30
08/11/2002	07:19	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
07/11/2002	18:08	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
05/11/2002	16:02	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
01/11/2002	13:47	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
30/10/2002	15:03	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
29/10/2002	14:00	UK Regulatory	Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy	LSE:BC43	Inter-amer 30
23/10/2002	12:10	UK Regulatory	3rd Quarter Results	LSE:BC43	Inter-amer 30
22/10/2002	07:01	UK Regulatory	Alimta Continues To Show Versatility in Treating Different Cancers	LSE:BC43	Inter-amer 30
21/10/2002	20:15	UK Regulatory	Dividend Declaration	LSE:BC43	Inter-amer 30
18/10/2002	07:00	UK Regulatory	Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of Gemzar-Based Combination Regimens is Topic of Workshop	LSE:BC43	Inter-amer 30
01/10/2002	14:10	UK Regulatory	Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene HCl- in Reducing Risk of Spinal Fractures	LSE:BC43	Inter-amer 30
25/09/2002	21:59	UK Regulatory	Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of	LSE:BC43	Inter-amer 30
24/09/2002	21:39	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
24/09/2002	00:05	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
20/09/2002	13:07	UK Regulatory	Statement re	LSE:BC43	Inter-amer 30
17/09/2002	14:34	UK Regulatory	Lilly Launches World's Largest Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients w	LSE:BC43	Inter-amer 30
16/09/2002	17:02	UK Regulatory	FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression; From the Makers of Prozac, Cymbalta Will Offer Ne	LSE:BC43	Inter-amer 30
16/09/2002	14:04	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
03/09/2002	14:08	UK Regulatory	Tadalafil for the Treatment of Erectile Dysfunction Receives Positive Recommendation From the Australian Drug Evaluation Committ	LSE:BC43	Inter-amer 30
26/08/2002	19:11	UK Regulatory	Regulatory Approval	LSE:BC43	Inter-amer 30
26/08/2002	15:44	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
14/08/2002	19:02	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
14/08/2002	16:56	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
14/08/2002	13:29	UK Regulatory	FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Opti	LSE:BC43	Inter-amer 30
01/08/2002	07:23	UK Regulatory	Lilly's Xigris Becomes First and Only Medical Product Approved for BIPA Payment in Medicare Patients	LSE:BC43	Inter-amer 30
30/07/2002	14:50	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
25/07/2002	20:03	UK Regulatory	Lilly ICOS LLC	LSE:BC43	Inter-amer 30